3 Value Stocks Worth Investigating

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Separating the winners from the value traps is a tough challenge, and that’s where StockStory comes in. Our job is to find you high-quality companies that will stand the test of time. Keeping that in mind, here are three value stocks trading at big discounts to their intrinsic values.

Remitly (RELY)

Forward EV/EBITDA Ratio: 9.2x

With Amazon founder Jeff Bezos as an early investor, Remitly (NASDAQ:RELY) is an online platform that enables consumers to safely and quickly send money globally.

Why Is RELY a Top Pick?

1. Active Customers have increased by an average of 31.9% annually, giving it the potential for margin-accretive growth if it can develop valuable complementary products and features
2. Additional sales over the last three years increased its profitability as the 74.6% annual growth in its earnings per share outpaced its revenue
3. Free cash flow margin jumped by 24.7 percentage points over the last few years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends

Remitly’s stock price of $13.80 implies a valuation ratio of 9.2x forward EV/EBITDA. Is now the time to initiate a position? Find out in our full research report, it’s free.

Incyte (INCY)

Forward P/E Ratio: 14.3x

Founded in 1991 and evolving from a genomics research firm to a commercial-stage drug developer, Incyte (NASDAQ:INCY) is a biopharmaceutical company that discovers, develops, and commercializes proprietary therapeutics for cancer and inflammatory diseases.

Why Are We Fans of INCY?

1. Solid 15.5% annual revenue growth over the last two years indicates its offering’s solve complex business issues
2. Share buybacks catapulted its annual earnings per share growth to 60.8%, which outperformed its revenue gains over the last five years
3. Free cash flow margin grew by 6.8 percentage points over the last five years, giving the company more chips to play with

At $106.88 per share, Incyte trades at 14.3x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.

NerdWallet (NRDS)

Forward P/E Ratio: 9.1x

Born from founder Tim Chen's frustration with the lack of transparent credit card information when helping his sister in 2009, NerdWallet (NASDAQ:NRDS) is a digital platform that provides financial guidance to help consumers and small businesses make smarter decisions about credit cards, loans, insurance, and other financial products.

Why Does NRDS Stand Out?

1. Impressive 26.5% annual revenue growth over the last five years indicates it’s winning market share this cycle
2. Incremental sales over the last two years have been highly profitable as its earnings per share increased by 266% annually, topping its revenue gains

NerdWallet is trading at $12.90 per share, or 9.1x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Stocks We Like Even More

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.